Top

Osteoporosis International

Published in:

01-11-2016 | Letter

Osteoanabolic therapy: a valid option to reduce refracture risk after vertebral augmentation procedures?

Authors: M. Massarotti, G. Fabbriciani, M. Barbieri, M. De Santis, M. Bukhari

Published in: Osteoporosis International | Issue 11/2016

Excerpt

Dear Editor, …

Beall DP, Feldman RG, Gordon ML, Gruber BL, Lane JM, Valenzuela G, Yim D, Alam J, Krege JH, Krohn K (2016) Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study. Osteoporos Int 27:1191–1198. doi:10.1007/s00198-015-3353-1 CrossRefPubMed

Tseng YY, Su CH, Lui TN, Yeh YS, Yeh SH (2011) Prospective comparison of the therapeutic effect of teriparatide with that of combined vertebroplasty with antiresorptive agents for the treatment of new-onset adjacent vertebral compression fracture after percutaneous vertebroplasty. Osteoporos Int 23:1613–1622. doi:10.1007/s00198-011-1730-y CrossRefPubMedPubMedCentral

Glover SJ, Eastell R, McCloskey EV, Rogers A, Garnero P, Lowery J, Belleli R, Wright TM, John MR (2009) Rapid and robust response of biochemical markers of bone formation to teriparatide therapy. Bone 45:1053–1058. doi:10.1016/j.bone.2009.07.091 CrossRefPubMed

Li YA, Lin CL, Chang MC, Liu CL, Chen TH, Lai SC (2012) Subsequent vertebral fracture after vertebroplasty: incidence and analysis of risk factors. Spine (Phila Pa 1976) 37(3):179–183. doi:10.1097/BRS.0b013e3181f72b05 CrossRef

Title: Osteoanabolic therapy: a valid option to reduce refracture risk after vertebral augmentation procedures?
Authors: M. Massarotti
G. Fabbriciani
M. Barbieri
M. De Santis
M. Bukhari
Publication date: 01-11-2016
Publisher: Springer London
Published in: Osteoporosis International / Issue 11/2016
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-016-3659-7

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Osteoanabolic therapy: a valid option to reduce refracture risk after vertebral augmentation procedures?

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2016

Falling age-related incidence of hip fractures in women, but not men, in Northern Ireland: 2001–2011

Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis

Skeletal phenotypes in adult patients with osteogenesis imperfecta—correlations with COL1A1/COL1A2 genotype and collagen structure

Stroke increases the risk of hip fracture: a systematic review and meta-analysis

Selective protein depletion impairs bone growth and causes liver fatty infiltration in female rats: prevention by Spirulina alga

Secular trends in fracture incidence in the UK between 1990 and 2012